Vespa velutina chromosome 12, iVesVel2.1, whole genome shotgun sequence.
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota; Neoptera; Endopterygota; Hymenoptera; Apocrita; Aculeata; Vespoidea; Vespidae; Vespinae; Vespa.
REFSEQ INFORMATION: The reference sequence is identical to\nOU525134.1.\nAssembly name: iVesVel2.1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the WELLCOME SANGER INSTITUTE on\n2021/08/14. The original whole-genome shotgun project has the\naccession CAJVVP000000000.1.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Vespa velutina Annotation Release\n 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
U4/U6.U5 tri-snRNP-associated protein 1, transcript variant X2
COORDINATES: polyA evidence [ECO:0006239]
U4/U6.U5 tri-snRNP-associated protein 1, transcript variant X1
U4/U6.U5 tri-snRNP-associated protein 1 isoform X1
U4/U6.U5 tri-snRNP-associated protein 1 isoform X2
microtubule-associated protein tau, transcript variant X3
microtubule-associated protein tau, transcript variant X2
microtubule-associated protein tau, transcript variant X1
microtubule-associated protein 4 isoform X3
microtubule-associated protein 4 isoform X2
microtubule-associated protein 4 isoform X1
microtubule-associated protein tau, transcript variant X4
microtubule-associated protein 4 isoform X4
microtubule-associated protein tau, transcript variant X5
microtubule-associated protein tau isoform X5
myosin light chain alkali, transcript variant X1
myosin light chain alkali, transcript variant X2
protein unc-80 homolog, transcript variant X2
protein unc-80 homolog, transcript variant X1
protein unc-80 homolog, transcript variant X3
carboxypeptidase Q-like, transcript variant X3
carboxypeptidase Q-like, transcript variant X1
carboxypeptidase Q-like, transcript variant X2
CUGBP Elav-like family member 4, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
CUGBP Elav-like family member 4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
CUGBP Elav-like family member 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
CUGBP Elav-like family member 4, transcript variant X8
CUGBP Elav-like family member 4, transcript variant X1
CUGBP Elav-like family member 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
CUGBP Elav-like family member 4, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
CUGBP Elav-like family member 4, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
CUGBP Elav-like family member 4, transcript variant X14
CUGBP Elav-like family member 4, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
CUGBP Elav-like family member 4, transcript variant X10
CUGBP Elav-like family member 4, transcript variant X16
CUGBP Elav-like family member 4, transcript variant X17
CUGBP Elav-like family member 4, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
CUGBP Elav-like family member 4, transcript variant X20
CUGBP Elav-like family member 4, transcript variant X12
CUGBP Elav-like family member 4, transcript variant X18
CUGBP Elav-like family member 4, transcript variant X22
CUGBP Elav-like family member 4, transcript variant X11
CUGBP Elav-like family member 4, transcript variant X19
CUGBP Elav-like family member 4, transcript variant X9
CUGBP Elav-like family member 4, transcript variant X21
CUGBP Elav-like family member 4 isoform X6
CUGBP Elav-like family member 4 isoform X8
CUGBP Elav-like family member 4 isoform X7
CUGBP Elav-like family member 3 isoform X2
CUGBP Elav-like family member 3 isoform X4
CUGBP Elav-like family member 3 isoform X3
CUGBP Elav-like family member 4 isoform X5
CUGBP Elav-like family member 3 isoform X1
CUGBP Elav-like family member 4 isoform X10
CUGBP Elav-like family member 4 isoform X12
CUGBP Elav-like family member 4 isoform X15
CUGBP Elav-like family member 4 isoform X11
CUGBP Elav-like family member 4 isoform X9
CUGBP Elav-like family member 4 isoform X13
CUGBP Elav-like family member 4 isoform X14
uncharacterized LOC124953310, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC124953310, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC124953310, transcript variant X2
uncharacterized LOC124953312, transcript variant X1
uncharacterized LOC124953312, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
membrane-associated protein Hem, transcript variant X1
membrane-associated protein Hem, transcript variant X2
membrane-associated protein Hem isoform X1
membrane-associated protein Hem, transcript variant X3
membrane-associated protein Hem isoform X2
disintegrin and metalloproteinase domain-containing protein 10, transcript variant X4
disintegrin and metalloproteinase domain-containing protein 10, transcript variant X3
disintegrin and metalloproteinase domain-containing protein 10, transcript variant X2
disintegrin and metalloproteinase domain-containing protein 10, transcript variant X1
disintegrin and metalloproteinase domain-containing protein 10 isoform X4
disintegrin and metalloproteinase domain-containing protein 10 isoform X3
disintegrin and metalloproteinase domain-containing protein 10 isoform X2
disintegrin and metalloproteinase domain-containing protein 10 isoform X1
uncharacterized protein DDB_G0283697-like, transcript variant X2
uncharacterized protein DDB_G0283697-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized protein DDB_G0283697-like
uncharacterized LOC124953303, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC124953303, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein LOC124953303 isoform X1
uncharacterized protein LOC124953303 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 54% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 80% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 67% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 40% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein C15orf61 homolog, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized protein C15orf61 homolog, transcript variant X3
uncharacterized protein C15orf61 homolog, transcript variant X2
uncharacterized protein C15orf61 homolog, transcript variant X1
uncharacterized protein C15orf61 homolog
GTP-binding protein SAR1, transcript variant X3
GTP-binding protein SAR1, transcript variant X2
GTP-binding protein SAR1, transcript variant X1
flavin-containing monooxygenase FMO GS-OX5, transcript variant X3
flavin-containing monooxygenase FMO GS-OX5, transcript variant X6
flavin-containing monooxygenase FMO GS-OX5, transcript variant X5
flavin-containing monooxygenase FMO GS-OX5, transcript variant X1
flavin-containing monooxygenase FMO GS-OX5, transcript variant X2
flavin-containing monooxygenase FMO GS-OX5, transcript variant X4
flavin-containing monooxygenase FMO GS-OX5 isoform X4
flavin-containing monooxygenase FMO GS-OX5 isoform X3
flavin-containing monooxygenase FMO GS-OX5 isoform X1
flavin-containing monooxygenase FMO GS-OX5 isoform X2
protein-tyrosine sulfotransferase, transcript variant X2
protein-tyrosine sulfotransferase, transcript variant X1
ABC transporter G family member 14, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ABC transporter G family member 14, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ABC transporter G family member 14, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ABC transporter G family member 14 isoform X3
ABC transporter G family member 14 isoform X2
ABC transporter G family member 14 isoform X1
elongator complex protein 3, transcript variant X1
elongator complex protein 3, transcript variant X2
TBC1 domain family member 1, transcript variant X4
TBC1 domain family member 1, transcript variant X5
TBC1 domain family member 1, transcript variant X2
TBC1 domain family member 1, transcript variant X3
TBC1 domain family member 1, transcript variant X1
TBC1 domain family member 1, transcript variant X6
ras-related protein Rap-2a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ras-related protein Rap-2a, transcript variant X4
ras-related protein Rap-2a, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ras-related protein Rap-2a, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ras-related protein Rap-2a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
leucine-rich PPR motif-containing protein, mitochondrial-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
leucine-rich PPR motif-containing protein, mitochondrial-like, transcript variant X2
leucine-rich PPR motif-containing protein, mitochondrial-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
leucine-rich PPR motif-containing protein, mitochondrial-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
leucine-rich PPR motif-containing protein, mitochondrial-like isoform X1
leucine-rich PPR motif-containing protein, mitochondrial-like isoform X3
leucine-rich PPR motif-containing protein, mitochondrial-like isoform X2
leucine-rich PPR motif-containing protein, mitochondrial-like isoform X6
leucine-rich PPR motif-containing protein, mitochondrial-like, transcript variant X4
leucine-rich PPR motif-containing protein, mitochondrial-like, transcript variant X5
leucine-rich PPR motif-containing protein, mitochondrial-like isoform X4
leucine-rich PPR motif-containing protein, mitochondrial-like isoform X5
facilitated trehalose transporter Tret1-like
lateral signaling target protein 2 homolog, transcript variant X2
lateral signaling target protein 2 homolog, transcript variant X1
lateral signaling target protein 2 homolog isoform X1
lateral signaling target protein 2 homolog isoform X2
uncharacterized LOC124953509, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC124953509, transcript variant X1
uncharacterized protein LOC124953509 isoform X2
uncharacterized protein LOC124953509 isoform X1
urea transporter 2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
urea transporter 2-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
urea transporter 2-like, transcript variant X7
urea transporter 2-like, transcript variant X5
urea transporter 2-like, transcript variant X2
urea transporter 2-like, transcript variant X6
urea transporter 2-like, transcript variant X1
uncharacterized LOC124953509, transcript variant X3
uncharacterized protein LOC124953509 isoform X3
collagen alpha chain CG42342-like, transcript variant X10
collagen alpha chain CG42342-like, transcript variant X15
collagen alpha chain CG42342-like, transcript variant X2
collagen alpha chain CG42342-like, transcript variant X1
collagen alpha chain CG42342-like, transcript variant X3
collagen alpha chain CG42342-like, transcript variant X9
collagen alpha chain CG42342-like, transcript variant X16
collagen alpha chain CG42342-like, transcript variant X19
collagen alpha chain CG42342-like, transcript variant X13
collagen alpha chain CG42342-like, transcript variant X5
collagen alpha chain CG42342-like, transcript variant X6
collagen alpha chain CG42342-like, transcript variant X12
collagen alpha chain CG42342-like, transcript variant X21
collagen alpha chain CG42342-like, transcript variant X11
collagen alpha chain CG42342-like, transcript variant X4
collagen alpha chain CG42342-like, transcript variant X8
collagen alpha chain CG42342-like, transcript variant X7
collagen alpha chain CG42342-like, transcript variant X14
collagen alpha chain CG42342-like, transcript variant X17
collagen alpha chain CG42342-like, transcript variant X20
collagen alpha chain CG42342-like, transcript variant X18
collagen alpha chain CG42342-like isoform X8
collagen alpha chain CG42342-like isoform X1
collagen alpha chain CG42342-like isoform X5
collagen alpha chain CG42342-like isoform X3
collagen alpha chain CG42342-like isoform X9
collagen alpha chain CG42342-like isoform X10
collagen alpha chain CG42342-like isoform X16
collagen alpha chain CG42342-like isoform X15
collagen alpha chain CG42342-like isoform X19
collagen alpha chain CG42342-like isoform X21
collagen alpha chain CG42342-like isoform X7
collagen alpha chain CG42342-like isoform X2
collagen alpha chain CG42342-like isoform X11
collagen alpha chain CG42342-like isoform X14
collagen alpha chain CG42342-like isoform X4
collagen alpha chain CG42342-like isoform X6
collagen alpha chain CG42342-like isoform X17
collagen alpha chain CG42342-like isoform X18
collagen alpha chain CG42342-like isoform X12
collagen alpha chain CG42342-like isoform X13
collagen alpha chain CG42342-like isoform X20
putative uncharacterized protein DDB_G0282133
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 7 bases in 7 codons; deleted 3 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 7 bases in 7 codons; deleted 3 bases in 2 codons; substituted 4 bases at 4 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: AFG3-like protein 2
adenosine 5'-monophosphoramidase HINT3-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: adenosine 5'-monophosphoramidase HINT3-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC124953464
zinc finger CCCH domain-containing protein 13-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 47% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: zinc finger CCCH domain-containing protein 13-like
longitudinals lacking protein-like, transcript variant X17
longitudinals lacking protein-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
longitudinals lacking protein-like, transcript variant X22
longitudinals lacking protein-like, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
longitudinals lacking protein-like, transcript variant X30
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
longitudinals lacking protein-like, transcript variant X7
longitudinals lacking protein-like, transcript variant X3
longitudinals lacking protein-like, transcript variant X31
longitudinals lacking protein-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
longitudinals lacking protein-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
longitudinals lacking protein-like, transcript variant X21
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
longitudinals lacking protein-like, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
longitudinals lacking protein-like, transcript variant X29
longitudinals lacking protein-like, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
longitudinals lacking protein-like, transcript variant X18
longitudinals lacking protein-like, transcript variant X19
longitudinals lacking protein-like, transcript variant X16
longitudinals lacking protein-like, transcript variant X32
longitudinals lacking protein-like, transcript variant X10
longitudinals lacking protein-like, transcript variant X28
longitudinals lacking protein-like, transcript variant X26
longitudinals lacking protein-like, transcript variant X20
longitudinals lacking protein-like, transcript variant X8
longitudinals lacking protein-like, transcript variant X23
longitudinals lacking protein-like, transcript variant X27
longitudinals lacking protein-like, transcript variant X33
longitudinals lacking protein-like, transcript variant X24
longitudinals lacking protein-like, transcript variant X25
longitudinals lacking protein-like, transcript variant X13
longitudinals lacking protein-like, transcript variant X14
longitudinals lacking protein-like, transcript variant X1
longitudinals lacking protein-like, transcript variant X11
longitudinals lacking protein-like, transcript variant X2
longitudinals lacking protein-like isoform X15
longitudinals lacking protein, isoforms F/I/K/T-like isoform X5
longitudinals lacking protein, isoforms A/B/D/L-like isoform X11
longitudinals lacking protein, isoforms A/B/D/L-like isoform X26
longitudinals lacking protein-like isoform X6
longitudinals lacking protein-like isoform X2
longitudinals lacking protein-like isoform X27
longitudinals lacking protein-like isoform X4
longitudinals lacking protein, isoforms A/B/D/L-like isoform X3
longitudinals lacking protein-like isoform X17
longitudinals lacking protein, isoforms A/B/D/L-like isoform X8
longitudinals lacking protein, isoforms A/B/D/L-like isoform X25
longitudinals lacking protein, isoforms A/B/D/L-like isoform X14
longitudinals lacking protein, isoforms N/O/W/X/Y-like isoform X28
longitudinals lacking protein, isoforms A/B/D/L-like isoform X9
longitudinals lacking protein, isoforms A/B/D/L-like isoform X24
longitudinals lacking protein, isoforms N/O/W/X/Y-like isoform X22
longitudinals lacking protein, isoforms N/O/W/X/Y-like isoform X16
zinc finger and BTB domain-containing protein 5-like isoform X7
longitudinals lacking protein, isoforms A/B/D/L-like isoform X19
zinc finger and BTB domain-containing protein 17-like isoform X20
zinc finger and BTB domain-containing protein 17-like isoform X21
zinc finger and BTB domain-containing protein 9-like isoform X1
longitudinals lacking protein, isoforms A/B/D/L-like isoform X10
longitudinals lacking protein, isoforms A/B/D/L-like
zinc finger and BTB domain-containing protein 18.2-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC124953498
cytochrome c oxidase assembly protein COX11, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
cytosolic Fe-S cluster assembly factor NUBP1 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
protein N-terminal asparagine amidohydrolase, transcript variant X2
protein N-terminal asparagine amidohydrolase, transcript variant X1
protein N-terminal asparagine amidohydrolase, transcript variant X3
protein N-terminal asparagine amidohydrolase, transcript variant X4
protein N-terminal asparagine amidohydrolase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
cullin-associated NEDD8-dissociated protein 1, transcript variant X2
cullin-associated NEDD8-dissociated protein 1, transcript variant X1
cullin-associated NEDD8-dissociated protein 1, transcript variant X3
cullin-associated NEDD8-dissociated protein 1 isoform X1
cullin-associated NEDD8-dissociated protein 1 isoform X2
ribonucleoside-diphosphate reductase subunit M2 B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ribonucleoside-diphosphate reductase subunit M2 B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ribonucleoside-diphosphate reductase subunit M2 B isoform X1
ribonucleoside-diphosphate reductase subunit M2 B isoform X3
ribonucleoside-diphosphate reductase subunit M2 B, transcript variant X2
ribonucleoside-diphosphate reductase subunit M2 B isoform X2
1,2-dihydroxy-3-keto-5-methylthiopentene dioxygenase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
phospholipid scramblase 1, transcript variant X1
phospholipid scramblase 1, transcript variant X2
phospholipid scramblase 1, transcript variant X3
homeobox protein orthopedia B-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
homeobox protein orthopedia B-like, transcript variant X1
homeobox protein orthopedia B-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
homeobox protein orthopedia B-like, transcript variant X2
homeobox protein orthopedia B-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
homeobox protein orthopedia B-like isoform X1
homeobox protein orthopedia B-like isoform X2
transcription termination factor 5, mitochondrial, transcript variant X1
transcription termination factor 5, mitochondrial isoform X1
transcription termination factor 5, mitochondrial, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized protein LOC124953260 isoform X2
translation initiation factor eIF-2B subunit delta, transcript variant X1
translation initiation factor eIF-2B subunit delta, transcript variant X6
translation initiation factor eIF-2B subunit delta, transcript variant X3
translation initiation factor eIF-2B subunit delta, transcript variant X4
translation initiation factor eIF-2B subunit delta, transcript variant X2
translation initiation factor eIF-2B subunit delta, transcript variant X5
translation initiation factor eIF-2B subunit delta isoform X1
translation initiation factor eIF-2B subunit delta isoform X2
translation initiation factor eIF-2B subunit delta, transcript variant X7
uncharacterized protein LOC124953258 isoform X3
probable peroxisomal acyl-coenzyme A oxidase 1
uncharacterized LOC124953478, transcript variant X1
uncharacterized LOC124953478, transcript variant X12
uncharacterized LOC124953478, transcript variant X11
uncharacterized LOC124953478, transcript variant X8
uncharacterized LOC124953478, transcript variant X7
uncharacterized LOC124953478, transcript variant X6
uncharacterized LOC124953478, transcript variant X2
uncharacterized LOC124953478, transcript variant X9
uncharacterized LOC124953478, transcript variant X3
uncharacterized LOC124953478, transcript variant X5
uncharacterized LOC124953478, transcript variant X4
uncharacterized LOC124953478, transcript variant X10
uncharacterized protein LOC124953478 isoform X12
uncharacterized protein LOC124953478 isoform X11
uncharacterized protein LOC124953478 isoform X8
uncharacterized protein LOC124953478 isoform X7
uncharacterized protein LOC124953478 isoform X6
uncharacterized protein LOC124953478 isoform X2
uncharacterized protein LOC124953478 isoform X9
uncharacterized protein LOC124953478 isoform X3
uncharacterized protein LOC124953478 isoform X5
uncharacterized protein LOC124953478 isoform X4
uncharacterized protein LOC124953478 isoform X10
uncharacterized protein LOC124953478 isoform X1
protein scarlet-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protein scarlet-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protein scarlet-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protein scarlet-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
protein scarlet-like, transcript variant X7
protein scarlet-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC124953488, transcript variant X3
uncharacterized LOC124953488, transcript variant X1
uncharacterized LOC124953488, transcript variant X2
protein scarlet-like, transcript variant X2
protein scarlet-like, transcript variant X3
protein scarlet-like, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protein brown-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
protein brown-like, transcript variant X2
protein brown-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
protein brown-like, transcript variant X4
ras-related protein Rab-32, transcript variant X4
ras-related protein Rab-32, transcript variant X5
ras-related protein Rab-32, transcript variant X2
ras-related protein Rab-32, transcript variant X1
ras-related protein Rab-32, transcript variant X3
ras-related protein Rab-32, transcript variant X6
uncharacterized protein LOC124953482 isoform X3
uncharacterized protein LOC124953482 isoform X2
ras and EF-hand domain-containing protein homolog isoform X1
conserved oligomeric Golgi complex subunit 1, transcript variant X2
conserved oligomeric Golgi complex subunit 1, transcript variant X1
conserved oligomeric Golgi complex subunit 1, transcript variant X3
conserved oligomeric Golgi complex subunit 1 isoform X1
conserved oligomeric Golgi complex subunit 1 isoform X2
conserved oligomeric Golgi complex subunit 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
sodium/hydrogen exchanger 6, transcript variant X1
sodium/hydrogen exchanger 6, transcript variant X2
sodium/hydrogen exchanger 6, transcript variant X5
sodium/hydrogen exchanger 6, transcript variant X11
sodium/hydrogen exchanger 6, transcript variant X8
sodium/hydrogen exchanger 6, transcript variant X3
sodium/hydrogen exchanger 6, transcript variant X4
sodium/hydrogen exchanger 6, transcript variant X6
sodium/hydrogen exchanger 6, transcript variant X9
sodium/hydrogen exchanger 6, transcript variant X10
sodium/hydrogen exchanger 6, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
metallo-beta-lactamase domain-containing protein 1, transcript variant X1
metallo-beta-lactamase domain-containing protein 1, transcript variant X2
metallo-beta-lactamase domain-containing protein 1 isoform X2
metallo-beta-lactamase domain-containing protein 1 isoform X1
FUN14 domain-containing protein 1A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized protein LOC124953253 isoform X3
FUN14 domain-containing protein 1A, transcript variant X4
FUN14 domain-containing protein 1A, transcript variant X2
FUN14 domain-containing protein 1A, transcript variant X1
uncharacterized protein LOC124953253 isoform X2
uncharacterized protein LOC124953253 isoform X1
FUN14 domain-containing protein 2 isoform X4
FUN14 domain-containing protein 1A, transcript variant X5
FUN14 domain-containing protein 1A isoform X5
histone demethylase UTY, transcript variant X3
histone demethylase UTY, transcript variant X1
histone demethylase UTY, transcript variant X2
histone demethylase UTY, transcript variant X5
histone demethylase UTY, transcript variant X7
histone demethylase UTY, transcript variant X6
histone demethylase UTY, transcript variant X4
histone demethylase UTY, transcript variant X8
histone demethylase UTY, transcript variant X9
adenylyl cyclase 78C, transcript variant X1
adenylyl cyclase 78C, transcript variant X3
adenylyl cyclase 78C, transcript variant X4
adenylyl cyclase 78C, transcript variant X2
adenylyl cyclase 78C, transcript variant X5
adenylyl cyclase 78C, transcript variant X6
adenylyl cyclase 78C, transcript variant X8
adenylyl cyclase 78C, transcript variant X7
tudor domain-containing protein 7-like, transcript variant X3
tudor domain-containing protein 7-like, transcript variant X2
tudor domain-containing protein 7-like, transcript variant X1
trafficking protein particle complex subunit 8
dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial, transcript variant X2
dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial, transcript variant X1
dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 47 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
DNA-directed RNA polymerase III subunit RPC6, transcript variant X2
DNA-directed RNA polymerase III subunit RPC6, transcript variant X1
probable DNA-directed RNA polymerase III subunit RPC6 isoform X1
DNA-directed RNA polymerase III subunit RPC6 isoform X2
ubiquitin-conjugating enzyme E2 S, transcript variant X1
ubiquitin-conjugating enzyme E2 S isoform X1
ubiquitin-conjugating enzyme E2 S, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ubiquitin-conjugating enzyme E2 S isoform X2
ADP-ribosylation factor-like protein 6-interacting protein 1
peroxisomal membrane protein 11B, transcript variant X2
peroxisomal membrane protein 11B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
heme transporter hrg1-A-like, transcript variant X5
heme transporter hrg1-A-like, transcript variant X4
heme transporter hrg1-A-like, transcript variant X3
heme transporter hrg1-A-like, transcript variant X2
uncharacterized protein LOC124953265 isoform X3
heme transporter hrg1-A-like, transcript variant X1
uncharacterized protein LOC124953265 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 81% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC124953263, transcript variant X4
uncharacterized protein LOC124953263 isoform X3
uncharacterized LOC124953263, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC124953263, transcript variant X3
uncharacterized LOC124953263, transcript variant X1
uncharacterized protein LOC124953263 isoform X2
uncharacterized protein LOC124953263 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC124953283, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC124953283, transcript variant X2
uncharacterized LOC124953283, transcript variant X3
U8-agatoxin-Ao1a-like, transcript variant X2
U8-agatoxin-Ao1a-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
nuclear transcription factor Y subunit alpha, transcript variant X3
nuclear transcription factor Y subunit alpha, transcript variant X4
nuclear transcription factor Y subunit alpha, transcript variant X2
nuclear transcription factor Y subunit alpha, transcript variant X1
nuclear transcription factor Y subunit alpha
arginine/serine-rich coiled-coil protein 2, transcript variant X3
arginine/serine-rich coiled-coil protein 2, transcript variant X1
arginine/serine-rich coiled-coil protein 2 isoform X1
arginine/serine-rich coiled-coil protein 2, transcript variant X2
arginine/serine-rich coiled-coil protein 2 isoform X2
arginine/serine-rich coiled-coil protein 2 isoform X3
apolipoprotein D-like, transcript variant X1
apolipoprotein D-like, transcript variant X2
phospholipase A2 isozymes PA3A/PA3B/PA5, transcript variant X1
phospholipase A2 isozymes PA3A/PA3B/PA5, transcript variant X3
phospholipase A2 isozymes PA3A/PA3B/PA5, transcript variant X2
phospholipase A2 isozymes PA3A/PA3B/PA5 isoform X2
uncharacterized protein LOC124953426 isoform X1
coiled-coil domain-containing protein 86
Fanconi anemia group J protein homolog, transcript variant X2
Fanconi anemia group J protein homolog, transcript variant X1
Fanconi anemia group J protein homolog isoform X1
Fanconi anemia group J protein homolog isoform X2
optomotor-blind protein, transcript variant X3
optomotor-blind protein, transcript variant X7
optomotor-blind protein, transcript variant X6
optomotor-blind protein, transcript variant X1
optomotor-blind protein, transcript variant X5
optomotor-blind protein, transcript variant X8
optomotor-blind protein, transcript variant X4
optomotor-blind protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 86% coverage of the annotated genomic feature by RNAseq alignments
histone acetyltransferase KAT6B-like, transcript variant X1
histone acetyltransferase KAT6B-like, transcript variant X2
uncharacterized protein LOC124953494 isoform X1
histone acetyltransferase KAT6B-like isoform X2
LIM domain kinase 1, transcript variant X2
LIM domain kinase 1, transcript variant X1
protein HGH1 homolog, transcript variant X1
protein HGH1 homolog, transcript variant X2
uncharacterized LOC124953318, transcript variant X1
uncharacterized LOC124953318, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized protein LOC124953318 isoform X1
uncharacterized LOC124953318, transcript variant X3
uncharacterized protein LOC124953318 isoform X2
uncharacterized LOC124953344, transcript variant X1
uncharacterized LOC124953344, transcript variant X3
uncharacterized LOC124953344, transcript variant X2
uncharacterized protein LOC124953344 isoform X1
uncharacterized LOC124953344, transcript variant X4
uncharacterized protein LOC124953344 isoform X2
uncharacterized LOC124953548, transcript variant X4
uncharacterized LOC124953548, transcript variant X2
uncharacterized LOC124953548, transcript variant X3
uncharacterized LOC124953548, transcript variant X1
vacuolar protein-sorting-associated protein 36
uncharacterized LOC124953332, transcript variant X2
uncharacterized LOC124953332, transcript variant X1
caseinolytic peptidase B protein homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
97 kDa heat shock protein, transcript variant X1
97 kDa heat shock protein, transcript variant X2
vacuolar ATPase assembly integral membrane protein VMA21 homolog
uncharacterized LOC124953243, transcript variant X1
uncharacterized LOC124953243, transcript variant X2
uncharacterized LOC124953243, transcript variant X3
uncharacterized protein LOC124953243 isoform X1
uncharacterized protein LOC124953243 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments
calcium-dependent secretion activator, transcript variant X3
calcium-dependent secretion activator, transcript variant X7
calcium-dependent secretion activator, transcript variant X5
calcium-dependent secretion activator, transcript variant X6
calcium-dependent secretion activator, transcript variant X4
calcium-dependent secretion activator, transcript variant X1
calcium-dependent secretion activator, transcript variant X2
calcium-dependent secretion activator isoform X5
calcium-dependent secretion activator isoform X3
calcium-dependent secretion activator isoform X4
calcium-dependent secretion activator isoform X2
calcium-dependent secretion activator isoform X1
beta-1,3-galactosyltransferase 5-like, transcript variant X1
beta-1,3-galactosyltransferase 5-like, transcript variant X2
WW domain-binding protein 2, transcript variant X2
WW domain-binding protein 2, transcript variant X1
ubiquitin domain-containing protein UBFD1-like, transcript variant X2
ubiquitin domain-containing protein UBFD1-like, transcript variant X3
ubiquitin domain-containing protein UBFD1-like, transcript variant X5
ubiquitin domain-containing protein UBFD1-like, transcript variant X4
ubiquitin domain-containing protein UBFD1-like, transcript variant X1
ubiquitin domain-containing protein UBFD1-like, transcript variant X6
ubiquitin domain-containing protein UBFD1-like isoform X3
ubiquitin domain-containing protein UBFD1-like isoform X2
ubiquitin domain-containing protein UBFD1-like isoform X1
ubiquitin domain-containing protein UBFD1-like isoform X4
polycomb protein suz12-B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
polycomb protein suz12-B, transcript variant X1
polycomb protein suz12-B, transcript variant X3
methyltransferase-like protein 22, transcript variant X4
methyltransferase-like protein 22, transcript variant X3
methyltransferase-like protein 22, transcript variant X2
methyltransferase-like protein 22, transcript variant X5
methyltransferase-like protein 22, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
methyltransferase-like protein 22 isoform X1
methyltransferase-like protein 22 isoform X2
protein disulfide-isomerase, transcript variant X2
protein disulfide-isomerase, transcript variant X1
protein disulfide-isomerase, transcript variant X3
protein disulfide-isomerase, transcript variant X4
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 2 bases in 1 codon; substituted 3 bases at 3 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC124953529
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 5 bases in 4 codons; deleted 3 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 50% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 5 bases in 4 codons; deleted 3 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: protein disulfide-isomerase TMX3
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA leucine (anticodon AAG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
3-hydroxyisobutyryl-CoA hydrolase, mitochondrial-like, transcript variant X3
3-hydroxyisobutyryl-CoA hydrolase, mitochondrial-like, transcript variant X1
3-hydroxyisobutyryl-CoA hydrolase, mitochondrial-like, transcript variant X2
3-hydroxyisobutyryl-CoA hydrolase, mitochondrial-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 27% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: peptide deformylase, mitochondrial-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: tachykinin-like peptides receptor 99D
uncharacterized LOC124953342, transcript variant X2
uncharacterized LOC124953342, transcript variant X1
sphingosine-1-phosphate lyase, transcript variant X2
sphingosine-1-phosphate lyase, transcript variant X1
sphingosine-1-phosphate lyase, transcript variant X3
sphingosine-1-phosphate lyase isoform X1
sphingosine-1-phosphate lyase isoform X2
tubby-related protein 4, transcript variant X5
tubby-related protein 4, transcript variant X4
tubby-related protein 4, transcript variant X2
tubby-related protein 4, transcript variant X3
tubby-related protein 4, transcript variant X1
tubby-related protein 4, transcript variant X9
tubby-related protein 4, transcript variant X8
tubby-related protein 4, transcript variant X7
tubby-related protein 4, transcript variant X6
tubby-related protein 4, transcript variant X10
tubby-related protein 4, transcript variant X12
tubby-related protein 4, transcript variant X11
NADP-dependent malic enzyme, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
NADP-dependent malic enzyme, transcript variant X1
NADP-dependent malic enzyme, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
suppressor of lurcher protein 1, transcript variant X5
suppressor of lurcher protein 1 isoform X2
suppressor of lurcher protein 1, transcript variant X3
suppressor of lurcher protein 1, transcript variant X2
suppressor of lurcher protein 1, transcript variant X1
suppressor of lurcher protein 1, transcript variant X4
suppressor of lurcher protein 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC124953410, transcript variant X6
uncharacterized LOC124953410, transcript variant X4
uncharacterized LOC124953410, transcript variant X2
uncharacterized LOC124953410, transcript variant X3
uncharacterized LOC124953410, transcript variant X7
uncharacterized LOC124953410, transcript variant X5
uncharacterized LOC124953410, transcript variant X1
uncharacterized protein LOC124953410 isoform X1
uncharacterized protein LOC124953410 isoform X2
uncharacterized LOC124953389, transcript variant X2
uncharacterized LOC124953389, transcript variant X3
uncharacterized LOC124953389, transcript variant X4
uncharacterized LOC124953389, transcript variant X1
uncharacterized protein LOC124953389 isoform X2
uncharacterized protein LOC124953389 isoform X1
WD repeat-containing protein 44, transcript variant X4
WD repeat-containing protein 44, transcript variant X2
WD repeat-containing protein 44, transcript variant X3
WD repeat-containing protein 44, transcript variant X1
WD repeat-containing protein 44 isoform X4
WD repeat-containing protein 44 isoform X2
WD repeat-containing protein 44 isoform X3
WD repeat-containing protein 44 isoform X1
synaptic functional regulator FMR1, transcript variant X6
synaptic functional regulator FMR1, transcript variant X1
synaptic functional regulator FMR1, transcript variant X7
synaptic functional regulator FMR1, transcript variant X4
synaptic functional regulator FMR1, transcript variant X2
synaptic functional regulator FMR1, transcript variant X3
synaptic functional regulator FMR1, transcript variant X5
synaptic functional regulator FMR1 isoform X1
synaptic functional regulator FMR1 isoform X4
synaptic functional regulator FMR1 isoform X2
synaptic functional regulator FMR1 isoform X3
synaptic functional regulator FMR1 isoform X5
synaptic functional regulator FMR1 isoform X6
synaptic functional regulator FMR1 isoform X7
E3 ubiquitin-protein ligase RNF19A-like, transcript variant X2
E3 ubiquitin-protein ligase RNF19A-like, transcript variant X4
E3 ubiquitin-protein ligase RNF19A-like, transcript variant X3
E3 ubiquitin-protein ligase RNF19A-like, transcript variant X1
E3 ubiquitin-protein ligase RNF19A-like isoform X2
E3 ubiquitin-protein ligase RNF19A-like isoform X1
E3 ubiquitin-protein ligase RNF19A-like isoform X4
E3 ubiquitin-protein ligase RNF19A-like isoform X3
uncharacterized LOC124953225, transcript variant X4
uncharacterized LOC124953225, transcript variant X2
uncharacterized LOC124953225, transcript variant X1
uncharacterized LOC124953225, transcript variant X5
uncharacterized LOC124953225, transcript variant X3
trafficking protein particle complex subunit 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
sodium-dependent proline transporter-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
acid sphingomyelinase-like phosphodiesterase 3b, transcript variant X12
acid sphingomyelinase-like phosphodiesterase 3b isoform X6
uncharacterized LOC124953233, transcript variant X1
uncharacterized LOC124953233, transcript variant X2
uncharacterized LOC124953231, transcript variant X3
acid sphingomyelinase-like phosphodiesterase 3b, transcript variant X13
acid sphingomyelinase-like phosphodiesterase 3b isoform X7
acid sphingomyelinase-like phosphodiesterase 3b, transcript variant X10
acid sphingomyelinase-like phosphodiesterase 3b isoform X4
acid sphingomyelinase-like phosphodiesterase 3b, transcript variant X8
acid sphingomyelinase-like phosphodiesterase 3b, transcript variant X5
acid sphingomyelinase-like phosphodiesterase 3b, transcript variant X4
acid sphingomyelinase-like phosphodiesterase 3b, transcript variant X3
acid sphingomyelinase-like phosphodiesterase 3b, transcript variant X16
acid sphingomyelinase-like phosphodiesterase 3b, transcript variant X14
acid sphingomyelinase-like phosphodiesterase 3b, transcript variant X2
acid sphingomyelinase-like phosphodiesterase 3b, transcript variant X15
acid sphingomyelinase-like phosphodiesterase 3b, transcript variant X7
acid sphingomyelinase-like phosphodiesterase 3b, transcript variant X1
acid sphingomyelinase-like phosphodiesterase 3b, transcript variant X6
acid sphingomyelinase-like phosphodiesterase 3b, transcript variant X17
acid sphingomyelinase-like phosphodiesterase 3b isoform X1
acid sphingomyelinase-like phosphodiesterase 3b isoform X2
acid sphingomyelinase-like phosphodiesterase 3b isoform X8
acid sphingomyelinase-like phosphodiesterase 3b, transcript variant X11
acid sphingomyelinase-like phosphodiesterase 3b isoform X5
acid sphingomyelinase-like phosphodiesterase 3b, transcript variant X9
acid sphingomyelinase-like phosphodiesterase 3b isoform X3
uncharacterized LOC124953231, transcript variant X4
uncharacterized LOC124953231, transcript variant X1
uncharacterized LOC124953231, transcript variant X2
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC124953533
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 113 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
odorant receptor Or2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
odorant receptor Or2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
odorant receptor Or2-like, transcript variant X3
inner membrane metabolite transport protein YgcS-like
uncharacterized LOC124953280, transcript variant X2
uncharacterized LOC124953280, transcript variant X1
uncharacterized protein LOC124953280 isoform X2
uncharacterized protein LOC124953280 isoform X1
replication protein A 70 kDa DNA-binding subunit
unconventional myosin ID, transcript variant X2
unconventional myosin ID, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
unconventional myosin ID, transcript variant X3
unconventional myosin ID, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
ras-related protein Rab-28-like, transcript variant X11
ras-related protein Rab-28-like, transcript variant X7
ras-related protein Rab-28-like, transcript variant X8
ras-related protein Rab-28-like, transcript variant X5
ras-related protein Rab-28-like, transcript variant X2
ras-related protein Rab-28-like, transcript variant X12
ras-related protein Rab-28-like, transcript variant X4
ras-related protein Rab-28-like, transcript variant X1
ras-related protein Rab-28-like, transcript variant X10
ras-related protein Rab-28-like, transcript variant X6
ras-related protein Rab-28-like, transcript variant X9
ras-related protein Rab-28-like, transcript variant X3
ras-related protein Rab-28-like isoform X2
ras-related protein Rab-28-like isoform X1
F-box/LRR-repeat protein 7, transcript variant X2
F-box/LRR-repeat protein 7, transcript variant X1
F-box/LRR-repeat protein 7, transcript variant X5
F-box/LRR-repeat protein 7, transcript variant X3
F-box/LRR-repeat protein 7, transcript variant X4
zinc transporter ZIP13 homolog, transcript variant X3
zinc transporter ZIP13 homolog, transcript variant X1
zinc transporter ZIP13 homolog, transcript variant X2
complement component 1 Q subcomponent-binding protein, mitochondrial
receptor-type guanylate cyclase daf-11, transcript variant X15
receptor-type guanylate cyclase daf-11, transcript variant X8
receptor-type guanylate cyclase daf-11, transcript variant X7
receptor-type guanylate cyclase daf-11, transcript variant X14
receptor-type guanylate cyclase daf-11, transcript variant X5
receptor-type guanylate cyclase daf-11, transcript variant X2
receptor-type guanylate cyclase daf-11, transcript variant X13
receptor-type guanylate cyclase daf-11, transcript variant X1
receptor-type guanylate cyclase daf-11, transcript variant X4
receptor-type guanylate cyclase daf-11, transcript variant X3
receptor-type guanylate cyclase daf-11, transcript variant X6
receptor-type guanylate cyclase daf-11, transcript variant X11
receptor-type guanylate cyclase daf-11, transcript variant X10
receptor-type guanylate cyclase daf-11, transcript variant X12
receptor-type guanylate cyclase daf-11, transcript variant X9
uncharacterized protein LOC124953471 isoform X3
receptor-type guanylate cyclase daf-11 isoform X1
receptor-type guanylate cyclase daf-11 isoform X2
geranylgeranyl transferase type-2 subunit alpha, transcript variant X1
geranylgeranyl transferase type-2 subunit alpha, transcript variant X2
geranylgeranyl transferase type-2 subunit alpha isoform X1
geranylgeranyl transferase type-2 subunit alpha isoform X2
phosducin-like protein, transcript variant X2
phosducin-like protein, transcript variant X1
purine nucleoside phosphorylase, transcript variant X2
purine nucleoside phosphorylase, transcript variant X6
purine nucleoside phosphorylase, transcript variant X1
purine nucleoside phosphorylase, transcript variant X5
purine nucleoside phosphorylase, transcript variant X3
purine nucleoside phosphorylase, transcript variant X4
purine nucleoside phosphorylase, transcript variant X7
purine nucleoside phosphorylase isoform X1
purine nucleoside phosphorylase isoform X2
purine nucleoside phosphorylase isoform X3
purine nucleoside phosphorylase isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 57% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC124953450, transcript variant X1
uncharacterized LOC124953450, transcript variant X2
uncharacterized protein LOC124953450 isoform X1
uncharacterized protein LOC124953450 isoform X2
uncharacterized LOC124953449, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC124953449, transcript variant X6
uncharacterized LOC124953449, transcript variant X4
uncharacterized LOC124953449, transcript variant X5
uncharacterized LOC124953449, transcript variant X8
uncharacterized LOC124953449, transcript variant X3
uncharacterized LOC124953449, transcript variant X2
uncharacterized LOC124953449, transcript variant X7
uncharacterized protein LOC124953449 isoform X1
uncharacterized protein LOC124953449 isoform X4
uncharacterized protein LOC124953449 isoform X5
uncharacterized protein LOC124953449 isoform X8
uncharacterized protein LOC124953449 isoform X3
uncharacterized protein LOC124953449 isoform X2
uncharacterized protein LOC124953449 isoform X6
uncharacterized protein LOC124953449 isoform X7
uncharacterized LOC124953449, transcript variant X9
uncharacterized protein LOC124953449 isoform X9
uncharacterized LOC124953453, transcript variant X3
uncharacterized LOC124953453, transcript variant X2
uncharacterized LOC124953453, transcript variant X1
uncharacterized protein LOC124953453 isoform X2
uncharacterized protein LOC124953453 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 74% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 60% coverage of the annotated genomic feature by RNAseq alignments
beta-1-syntrophin, transcript variant X1
beta-1-syntrophin, transcript variant X2
unconventional myosin-Va, transcript variant X2
unconventional myosin-Va, transcript variant X1
unconventional myosin-Va, transcript variant X3
unconventional myosin-Va, transcript variant X4
unconventional myosin-Va, transcript variant X6
unconventional myosin-Va, transcript variant X5
17-beta-hydroxysteroid dehydrogenase 13-like, transcript variant X3
17-beta-hydroxysteroid dehydrogenase 13-like, transcript variant X2
17-beta-hydroxysteroid dehydrogenase 13-like, transcript variant X1
short-chain dehydrogenase/reductase family 16C member 6-like isoform X2
17-beta-hydroxysteroid dehydrogenase 13-like isoform X1
17-beta-hydroxysteroid dehydrogenase 13-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
short-chain dehydrogenase/reductase family 16C member 6-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 78% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC124953271, transcript variant X2
uncharacterized LOC124953271, transcript variant X3
uncharacterized protein LOC124953271 isoform X2
uncharacterized LOC124953271, transcript variant X1
uncharacterized protein LOC124953271 isoform X1
uncharacterized LOC124953272, transcript variant X2
uncharacterized LOC124953272, transcript variant X1
uncharacterized protein LOC124953272 isoform X1
uncharacterized LOC124953272, transcript variant X3
uncharacterized protein LOC124953272 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
piggyBac transposable element-derived protein 4-like, transcript variant X6
piggyBac transposable element-derived protein 4-like, transcript variant X1
piggyBac transposable element-derived protein 4-like, transcript variant X4
piggyBac transposable element-derived protein 4-like, transcript variant X2
piggyBac transposable element-derived protein 4-like, transcript variant X3
piggyBac transposable element-derived protein 4-like, transcript variant X7
piggyBac transposable element-derived protein 4-like isoform X1
piggyBac transposable element-derived protein 4-like, transcript variant X5
piggyBac transposable element-derived protein 4-like isoform X3
piggyBac transposable element-derived protein 4-like isoform X2
active regulator of SIRT1-like, transcript variant X2
active regulator of SIRT1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
COP9 signalosome complex subunit 3, transcript variant X1
COP9 signalosome complex subunit 3, transcript variant X2
COP9 signalosome complex subunit 3 isoform X2
COP9 signalosome complex subunit 3 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
2-oxoglutarate and iron-dependent oxygenase domain-containing protein 3-like
serine/threonine-protein kinase ICK, transcript variant X1
serine/threonine-protein kinase ICK, transcript variant X2
serine/threonine-protein kinase ICK, transcript variant X3
serine/threonine-protein kinase ICK isoform X1
serine/threonine-protein kinase dyf-5 isoform X2
serine/threonine-protein kinase ICK isoform X3
equilibrative nucleoside transporter 4, transcript variant X1
equilibrative nucleoside transporter 4, transcript variant X2
putative uncharacterized protein DDB_G0282133, transcript variant X1
putative uncharacterized protein DDB_G0282133, transcript variant X2
LIM/homeobox protein Awh, transcript variant X2
LIM/homeobox protein Awh, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
LIM/homeobox protein Awh-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
LIM/homeobox protein Awh-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
LIM homeobox transcription factor 1-alpha-like isoform X1
LIM/homeobox protein Awh-like isoform X2
TBC1 domain family member 13, transcript variant X1
TBC1 domain family member 13, transcript variant X2
phospholipid-transporting ATPase ABCA1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 72% coverage of the annotated genomic feature by RNAseq alignments
short-chain dehydrogenase/reductase family 16C member 6-like, transcript variant X1
short-chain dehydrogenase/reductase family 16C member 6-like, transcript variant X2
short-chain dehydrogenase/reductase family 16C member 6-like isoform X1
sodium/potassium-transporting ATPase subunit beta-1-interacting protein, transcript variant X3
sodium/potassium-transporting ATPase subunit beta-1-interacting protein, transcript variant X1
sodium/potassium-transporting ATPase subunit beta-1-interacting protein, transcript variant X2
sodium/potassium-transporting ATPase subunit beta-1-interacting protein, transcript variant X5
sodium/potassium-transporting ATPase subunit beta-1-interacting protein, transcript variant X4
uncharacterized protein LOC124953287 isoform X1
uncharacterized protein LOC124953287 isoform X3
sodium/potassium-transporting ATPase subunit beta-1-interacting protein isoform X5
sodium/potassium-transporting ATPase subunit beta-1-interacting protein isoform X4
sodium/potassium-transporting ATPase subunit beta-1-interacting protein isoform X2
glutaminase kidney isoform, mitochondrial, transcript variant X6
glutaminase kidney isoform, mitochondrial, transcript variant X9
glutaminase kidney isoform, mitochondrial, transcript variant X7
glutaminase kidney isoform, mitochondrial, transcript variant X10
glutaminase kidney isoform, mitochondrial, transcript variant X8
glutaminase liver isoform, mitochondrial isoform X6
glutaminase liver isoform, mitochondrial isoform X8
glutaminase kidney isoform, mitochondrial isoform X9
glutaminase liver isoform, mitochondrial isoform X7
glutaminase kidney isoform, mitochondrial isoform X10
glutaminase kidney isoform, mitochondrial, transcript variant X1
glutaminase kidney isoform, mitochondrial, transcript variant X2
glutaminase kidney isoform, mitochondrial, transcript variant X4
glutaminase kidney isoform, mitochondrial, transcript variant X3
glutaminase kidney isoform, mitochondrial, transcript variant X11
glutaminase kidney isoform, mitochondrial, transcript variant X12
glutaminase kidney isoform, mitochondrial, transcript variant X5
glutaminase kidney isoform, mitochondrial, transcript variant X13
glutaminase liver isoform, mitochondrial isoform X1
glutaminase liver isoform, mitochondrial isoform X2
glutaminase liver isoform, mitochondrial isoform X3
glutaminase liver isoform, mitochondrial isoform X4
glutaminase kidney isoform, mitochondrial isoform X11
glutaminase kidney isoform, mitochondrial isoform X12
glutaminase liver isoform, mitochondrial isoform X5
glutaminase kidney isoform, mitochondrial isoform X13
uncharacterized transmembrane protein DDB_G0289901-like, transcript variant X2
uncharacterized transmembrane protein DDB_G0289901-like, transcript variant X1
uncharacterized transmembrane protein DDB_G0289901-like isoform X1
uncharacterized transmembrane protein DDB_G0289901-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC124953374, transcript variant X3
uncharacterized LOC124953374, transcript variant X1
uncharacterized LOC124953374, transcript variant X2
uncharacterized protein LOC124953374 isoform X1
uncharacterized protein LOC124953374 isoform X2
EF-hand calcium-binding domain-containing protein 1-like
ATP synthase subunit C lysine N-methyltransferase
sodium-coupled neutral amino acid transporter 9-like, transcript variant X4
sodium-coupled neutral amino acid transporter 9-like, transcript variant X3
sodium-coupled neutral amino acid transporter 9-like, transcript variant X1
sodium-coupled neutral amino acid transporter 9-like, transcript variant X2
sodium-coupled neutral amino acid transporter 9-like isoform X1
sodium-coupled neutral amino acid transporter 9-like isoform X2
sodium-coupled neutral amino acid transporter 9-like isoform X3
U3 small nucleolar ribonucleoprotein protein IMP3
uncharacterized LOC124953431, transcript variant X2
uncharacterized LOC124953431, transcript variant X1
uncharacterized LOC124953431, transcript variant X3
uncharacterized protein LOC124953431 isoform X1
uncharacterized protein LOC124953431 isoform X2
single-minded homolog 2, transcript variant X1
single-minded homolog 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
single-minded homolog 2, transcript variant X6
single-minded homolog 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
single-minded homolog 2, transcript variant X2
single-minded homolog 2, transcript variant X7
single-minded homolog 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
regulator of MON1-CCZ1 complex, transcript variant X2
regulator of MON1-CCZ1 complex, transcript variant X1
regulator of MON1-CCZ1 complex isoform X2
regulator of MON1-CCZ1 complex isoform X1
UBA-like domain-containing protein 2, transcript variant X1
UBA-like domain-containing protein 2, transcript variant X2
UBA-like domain-containing protein 2 isoform X2
uncharacterized protein LOC124953461 isoform X1
1-phosphatidylinositol 3-phosphate 5-kinase, transcript variant X1
1-phosphatidylinositol 3-phosphate 5-kinase, transcript variant X2
1-phosphatidylinositol 3-phosphate 5-kinase isoform X1
1-phosphatidylinositol 3-phosphate 5-kinase isoform X2
exocyst complex component 3, transcript variant X2
exocyst complex component 3, transcript variant X3
exocyst complex component 3, transcript variant X1
protein dissatisfaction-like, transcript variant X4
protein dissatisfaction-like, transcript variant X1
protein dissatisfaction-like, transcript variant X2
protein dissatisfaction-like, transcript variant X3
uncharacterized LOC124953568, transcript variant X1
uncharacterized LOC124953568, transcript variant X2
uncharacterized LOC124953566, transcript variant X4
uncharacterized LOC124953566, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC124953566, transcript variant X3
uncharacterized LOC124953566, transcript variant X2
inhibitor of nuclear factor kappa-B kinase subunit alpha-like, transcript variant X2
inhibitor of nuclear factor kappa-B kinase subunit alpha-like, transcript variant X1
inhibitor of nuclear factor kappa-B kinase subunit alpha-like, transcript variant X7
inhibitor of nuclear factor kappa-B kinase subunit alpha-like, transcript variant X5
inhibitor of nuclear factor kappa-B kinase subunit alpha-like, transcript variant X4
inhibitor of nuclear factor kappa-B kinase subunit alpha-like, transcript variant X8
inhibitor of nuclear factor kappa-B kinase subunit alpha-like, transcript variant X6
inhibitor of nuclear factor kappa-B kinase subunit alpha-like, transcript variant X3
inhibitor of nuclear factor kappa-B kinase subunit alpha-like, transcript variant X9
inhibitor of nuclear factor kappa-B kinase subunit alpha-like isoform X2
inhibitor of nuclear factor kappa-B kinase subunit alpha-like isoform X1
inhibitor of nuclear factor kappa-B kinase subunit alpha-like isoform X8
inhibitor of nuclear factor kappa-B kinase subunit alpha-like isoform X7
inhibitor of nuclear factor kappa-B kinase subunit alpha-like isoform X5
inhibitor of nuclear factor kappa-B kinase subunit alpha-like isoform X4
inhibitor of nuclear factor kappa-B kinase subunit alpha-like isoform X6
inhibitor of nuclear factor kappa-B kinase subunit alpha-like isoform X3
inhibitor of nuclear factor kappa-B kinase subunit alpha-like isoform X9
histone-lysine N-methyltransferase SETMAR-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins
uncharacterized LOC124953330, transcript variant X2
uncharacterized LOC124953330, transcript variant X1
uncharacterized LOC124953330, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 68% coverage of the annotated genomic feature by RNAseq alignments